Datafin

Data-driven stock analysis platform for global investors.

Sitemap
HomeScreenerValuationSector Analysis
Resources
LibraryDatafin GuideMetric MethodologyValuation MethodologiesFAQPricingWho Is Datafin?Communication
Legal
Privacy PolicyTerms of UseCookie PolicyKVKK NoticeRefund Policy
Data Sources

Financial data sourced from official regulatory filings and verified market data providers. Metrics calculated using GAAP/IFRS standards.

Disclaimer

The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

Investment decisions involve risk. Verify data independently and consult a licensed advisor when needed.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved.

Last updated: April 2026

SGRY PEER ANALYSIS

Surgery Partners Inc — metric-by-metric comparison with peers and the industry median

SGRYSurgery Partners Inc

🇺🇸 USA · NASDAQ · Healthcare · Medical Care Facilities

Value itDuel
PriceFinancialsPeers

Overall Profile & Returns

· Medical Care Facilities

Position Within Industry

0 = weak quartile, 100 = strong quartile
ValuationProfitabilityGrowthFinancial Health
SGRYIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year
Split-adjusted
SGRY-23.3%MPARK+19.8%SIA+28.3%REG-8.2%SNZ-29.9%RYM—
Year-to-Date (YTD)
SGRY+10.0%MPARK+12.1%SIA+15.0%REG-1.7%SNZ-29.3%RYM-29.7%
1-Year
Split-adjusted
SGRY-23.3%MD+98.8%SEM+10.7%ASTH+85.6%AVAH+104.9%ADUS-5.5%
Year-to-Date (YTD)
SGRY+10.0%MD+28.1%SEM+12.1%ASTH+89.1%AVAH+16.6%ADUS-1.5%

Key Metric Comparison

P/E

Lower is better
SGRY—MPARK13.50SIA51.46REG53.65SNZ5.90RYM—Median 20.18

ROE

Higher is better
SGRY-4.4%MPARK17.4%SIA6.1%REG—SNZ8.2%RYM-16.8%Median 7.6%

Net Margin

Higher is better
SGRY-2.3%MPARK10.1%SIA4.3%REG3.0%SNZ72.0%RYM-60.1%Median 3.7%

Revenue Growth

Higher is better
SGRY5.4%MPARK13.0%SIA16.7%REG14.2%SNZ13.3%RYM215.1%Median 10.2%

P/E

Lower is better
SGRY—MD13.06SEM15.52ASTH76.12AVAH8.09ADUS19.59Median 20.18

ROE

Higher is better
SGRY-4.4%MD20.9%SEM7.7%ASTH3.9%AVAH369.9%ADUS9.4%Median 7.6%

Net Margin

Higher is better
SGRY-2.3%MD9.0%SEM2.4%ASTH0.9%AVAH10.4%ADUS6.9%Median 3.7%

Revenue Growth

Higher is better
SGRY5.4%MD-2.3%SEM29.2%ASTH56.7%AVAH20.5%ADUS19.6%Median 10.2%

All Metrics

Valuation
MetricSGRYMPARKSIAREGSNZRYMInd. Median
P/E—13.5051.4653.655.90●—20.18
P/B1.291.932.70-68.14●0.460.311.95
EV/EBITDA6.295.85●19.9710.9120.31—11.19
P/S0.65●1.372.231.634.251.091.13
Financial Health
MetricSGRYMPARKSIAREGSNZRYMInd. Median
Current Ratio1.86●1.190.600.090.340.551.26
Debt/Equity238.6%50.0%165.1%-26.7%●59.6%39.0%59.9%
NetDebt/EBITDA4.010.926.97-1.1211.44-6.24●1.87
Profitability
MetricSGRYMPARKSIAREGSNZRYMInd. Median
Net Margin-2.3%10.1%4.3%3.0%72.0%●-60.1%3.7%
ROE-4.4%17.4%●6.1%—8.2%-16.8%7.6%
ROA-1.0%8.3%●2.0%1.6%3.0%-5.8%3.0%
EBITDA Margin28.7%27.7%17.2%13.5%47.9%●-21.8%13.8%
Growth + Dividend
MetricSGRYMPARKSIAREGSNZRYMInd. Median
Rev. Growth5.4%13.0%16.7%14.2%13.3%215.1%●10.2%
NI Growth—-17.4%31.7%152.1%●-23.6%—17.0%
Div. Yield—0.4%4.1%●2.7%3.4%—1.1%
Payout—5.9%154.7%128.5%12.5%—12.7%
Valuation
MetricSGRYMDSEMASTHAVAHADUSInd. Median
P/E—13.0615.5276.128.09●19.5920.18
P/B1.292.591.16●2.888.821.751.95
EV/EBITDA6.29●9.239.6617.7411.4612.3511.19
P/S0.651.180.37●0.650.841.351.13
Financial Health
MetricSGRYMDSEMASTHAVAHADUSInd. Median
Current Ratio1.86●1.331.151.351.471.831.26
Debt/Equity238.6%71.7%170.3%133.1%625.8%12.4%●59.9%
NetDebt/EBITDA4.011.085.723.604.390.22●1.87
Profitability
MetricSGRYMDSEMASTHAVAHADUSInd. Median
Net Margin-2.3%9.0%2.4%0.9%10.4%●6.9%3.7%
ROE-4.4%20.9%7.7%3.9%369.9%●9.4%7.6%
ROA-1.0%8.6%2.3%1.6%14.2%●7.0%3.0%
EBITDA Margin28.7%●14.4%9.4%4.6%11.9%11.1%13.8%
Growth + Dividend
MetricSGRYMDSEMASTHAVAHADUSInd. Median
Rev. Growth5.4%-2.3%29.2%56.7%●20.5%19.6%10.2%
NI Growth——-23.2%-13.6%4,710.4%●26.3%17.0%
Div. Yield——1.5%●0.1%——1.1%
Payout——23.5%8.4%——12.7%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on SGRY

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 6, 26. This content is for informational purposes only and is not investment advice.